Pfizer CEO Warns Two Doses Of Vaccine ‘Not Enough’ For Omicron

During the 40th Annual J.P. Morgan Healthcare Conference on Monday, Pfizer CEO Albert Bourla said that two doses of the Pfizer/BioNTech COVID-19 vaccine are “not enough” for protection against the new Omicron variant. “Omicron is a way more challenging target, so the two doses are not enough for Omicron,” Bourla said. “The third dose of the current vaccine is providing good protection against death and decent protection against hospitalization. So, most of the people that they are ending up in hospital [with Omicron] aren’t vaccinated. They are not people that they had the vaccine.” “I think the question mark …


